Searchable abstracts of presentations at key conferences in endocrinology

ea0056s2.2 | Salt & Sweet | ECE2018

Hereditary diabetes insipidus

Rutishauser Jonas

Background: Families with inherited forms of diabetes insipidus (DI) have been described since the mid 19th century. Depending on the involved gene, the disorder is transmitted in autosomal dominant, autosomal recessive, or X-linked fashion.Nephrogenic DI: Patients typically have a severe phenotype manifesting shortly after birth. They are most often males with X-linked disease due to variations in the vasopressin V2 receptor (AVPR2) gene. Rarely, variat...

ea0081rc10.7 | Rapid Communications 10: Diabetes, Obesity, Metabolism and Nutrition 3 | ECE2022

Knowledge about Diabetic Ketoacidosis in Patients with Type 1 Diabetes mellitus – Data of a Patient-centered Questionnaire

Hepprich Matthias , Stiebitz Sebastian , Schultes Bernd , Schmitz Daniela , Felix Barbara , Rutishauser Jonas , Schubert Sabine , Roser Pia , Aberle Jens , Rudofsky Gottfried

Background/Introduction: Diabetic ketoacidosis (DKA) is a severe complication of diabetes mellitus type 1 (T1DM) with potentially life-threatening course. Data on patient knowledge about DKA in German-speaking countries is rare. Thus, we aimed to gather data about T1DM patientsÂ’ knowledge in terms of DKA.Methods: Together with two T1DM patients and an experienced diabetes counselor, we developed an anonymous questionnaire covering general knowledge ...

ea0032p702 | Neuroendocrinology | ECE2013

Copeptin for subtype differentiation of abnormal vasopressin release in SIADH: reclassification and characterization of a novel subtype

Fenske Wiebke , Horning Anna , Simet Jessica , Christ-Crain Mirjam , Szinnai Gabor , Rutishauser Jonas , Stork Stefan , Allolio Bruno

Introduction: The syndrome of inappropriate antidiuresis (SIADH) is the most common cause of hypoosmolality. Ectopic AVP hypersecretion has long been considered as the primaryn mechanism of SIADH. But different types of osmoregulatory defect in AVP release have been described in this disorder. A comprehensive characterization of these different forms of SIADH in a large cohort of patients may provide important new insights into the still incompletely understood pathophysiology...

ea0037ep796 | Pituitary: clinical | ECE2015

Changes in mid-regional pro-atrial natriuretic peptide during thirsting separate patients with diabetes insipidus from those with primary polydipsia

Urwyler Sandrine , Timper Katharina , Fenske Wiebke , Kuhn Felix , Frech Nica , Arici Birsen , Rutishauser Jonas , Kopp Peter , Allolio Bruno , Stettler Christoph , Muller Beat , Katan Mira , Christ-Crain Mirjam

Background: The water deprivation test as the accepted gold standard in the differential diagnosis of polyuria polydipsia syndrome can be associated with a decrease in extracellular fluid volume in patients with diabetes insipidus (DI). We herein evaluated mid-regional pro-atrial natriuretic peptide (MR-proANP) as marker of extracellular body volume in patients with diabetes insipidus compared to primary polydipsia (PP), at baseline and after water deprivation.<p class="ab...

ea0035oc3.2 | Neuroendocrinology &amp; Signalling | ECE2014

Copeptin in the diagnosis and differential diagnosis of diabetes dnsipidus – the ‘CoSIP-study’

Timper Katharina , Fenske Wiebke , Katan Mira , Kuehn Felix , Arici Birsen , Frech Nica , Rutishauser Jonas , Kopp Peter , Allolio Bruno , Stettler Christoph , Mueller Beat , Christ-Crain Mirjam

Introduction: The correct differential diagnosis of the disorders related to polyuria–polydipsia syndrome (PPS) is mandatory since inadequate treatment may lead to serious complications. The diagnostic gold standard is the water deprivation test (WDT) with direct or indirect measurement of plasma vasopressin (AVP). But test interpretation is problematic, and direct measurement of AVP is hampered by methodological difficulties. The aim of this study was to evaluate the dia...

ea0035p18 | Adrenal cortex | ECE2014

Adrenal function in glucocorticoid-treated patients with acute exacerbations of COPD: the ‘REDUCE*' randomized trial

Schuetz Philipp , Leuppi Joerg D , Bingisser Roland , Bodmer Michael , Briel Matthias , Drescher Tillman , Duerring Ursula , Henzen Christoph , Leibbrandt Yolanda , Maier Sabrina , Miedinger David , Muller Beat , Scherr Andreas , Schindler Christian , Stoeckli Rolf , Viatte Sebastien , von Garnier Christophe , Tamm Michael , Rutishauser Jonas

Introduction: Systemic glucocorticoid therapy may put patients at risk for later adrenal failure during times of stress, but tapering increases cumulative steroid exposure. We prospectively evaluated adrenal function and clinically relevant hypocortisolism after abruptly stopping prednisone treatment in patients with exacerbated COPD.Methods: This is a pre-specified analysis of the REDUCE randomized trial (Journal of American Medical Association...